MDX-2002

N/A

Report date: 2026/03/19 16:57:25

Base Information

Drug NameMDX-2002
Drug Alias NameLASER antibody (antibody)tetraspecific stealth lymphocyte activator and survival extension receptor antibody (ModeX Therapeutics)MDX-2002
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionT-cell-specific surface glycoprotein CD28 agonistsApoptosis regulator Bcl-X modulatorsT cell surface glycoprotein CD3 stimulants
TargetsApoptosis regulator Bcl-XT-cell-specific surface glycoprotein CD28T cell surface glycoprotein CD3
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesModeX Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesModeX Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A